Gerlinde Wernig

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

Medicine, Genetics, Hematology +14

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · PLoS Medicine · 2006 · 1.4K citations · Full text

Life Sciences, Genetics, Hematology +14

Preventing <i>Engrailed-1</i> activation in fibroblasts yields wound regeneration without scarring

Shamik Mascharak, Heather E. desJardins-Park, Michael F. Davitt et al. · Science · 2021 · 597 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types

Kyle M. Loh, Angela Chen, Pang Wei Koh et al. · Cell · 2016 · 511 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +15

Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model

Gerlinde Wernig, Thomas Mercher, Rachel Okabe et al. · Blood · 2006 · 473 citations · Full text

Medicine, Hematology, Pathology +13